|4Dec 6, 3:54 PM ET

Capstone Therapeutics Corp. 4

4 · Capstone Therapeutics Corp. · Filed Dec 6, 2013

Insider Transaction Report

Form 4
Period: 2013-12-06
HOLLIMAN JOHN M III
DirectorExecutive Chairman
Transactions
  • Purchase

    Common Stock

    2013-12-06$0.26/sh+25,000$6,500507,614 total
Holdings
  • Common Stock

    (indirect: Valley Ventures III, L.P.)
    1,658
  • Common Stock

    (indirect: By Trust)
    3,000

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES